HUP0102496A2 - Haemophilus parasuis vakcina és diagnosztikum - Google Patents

Haemophilus parasuis vakcina és diagnosztikum

Info

Publication number
HUP0102496A2
HUP0102496A2 HU0102496A HUP0102496A HUP0102496A2 HU P0102496 A2 HUP0102496 A2 HU P0102496A2 HU 0102496 A HU0102496 A HU 0102496A HU P0102496 A HUP0102496 A HU P0102496A HU P0102496 A2 HUP0102496 A2 HU P0102496A2
Authority
HU
Hungary
Prior art keywords
diagnostic
haemophilus parasuis
vaccine
haemophilus
parasuis vaccine
Prior art date
Application number
HU0102496A
Other languages
English (en)
Inventor
Douglas T. Burkhardt
Karen L. Lenz
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of HUP0102496A2 publication Critical patent/HUP0102496A2/hu
Publication of HUP0102496A3 publication Critical patent/HUP0102496A3/hu

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A találmány tárgyát képezi toxikus aktivitású Haemophilus parasuissejtkivonat és eljárás előállítására. A találmány tárgyát képeziktovábbá a sejtkivonatot tartalmazó vakcinák és tesztkészletek,valamint eljárások Haemophilus parasuis fertőzés diagnosztizálására. Asejtkivonat vakcinaként vagy diagnosztikai reagensként alkalmazható. Ó
HU0102496A 1998-07-01 1999-07-01 Haemophilus parasuis vaccine and diagnostic HUP0102496A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/108,438 US6342231B1 (en) 1998-07-01 1998-07-01 Haemophilus parasuis vaccine and diagnostic
PCT/US1999/014953 WO2000001408A2 (en) 1998-07-01 1999-07-01 Haemophilus parasuis vaccine and diagnostic

Publications (2)

Publication Number Publication Date
HUP0102496A2 true HUP0102496A2 (hu) 2001-10-28
HUP0102496A3 HUP0102496A3 (en) 2003-10-28

Family

ID=22322205

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0102496A HUP0102496A3 (en) 1998-07-01 1999-07-01 Haemophilus parasuis vaccine and diagnostic

Country Status (8)

Country Link
US (1) US6342231B1 (hu)
EP (1) EP1091756A2 (hu)
JP (1) JP2002519388A (hu)
AU (1) AU753763B2 (hu)
CA (1) CA2336320A1 (hu)
HU (1) HUP0102496A3 (hu)
PL (1) PL345954A1 (hu)
WO (1) WO2000001408A2 (hu)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY129765A (en) * 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
WO2004098741A2 (en) * 2003-04-30 2004-11-18 Biovitesse Apparatus and method for detecting live cells with an integrated filter and growth detection device
US8637047B2 (en) * 2003-10-30 2014-01-28 Boehringer Ingelheim Vetmedica, Inc. Erysipelothrix rhusiopathiae-haemophilus parasuis vaccine and methods of using the same
ES2330904B1 (es) * 2005-09-21 2010-09-23 Fundacio Centre De Recerca En Sanitat Animal Polinucleotidos de haemophilus parasuis y su uso.
US20110014237A1 (en) * 2008-03-26 2011-01-20 Ruud Philip Antoon Maria Segers Vaccine for Protection Against Haemophilus Parasuis Serotype 4 in Piglets
ES2617232T3 (es) * 2010-04-23 2017-06-15 Intervet International B.V. Una vacuna que comprende células inactivadas de bacterias Haemophilus parasuis de serotipo 5
CN102465145B (zh) * 2010-11-04 2013-04-17 华中农业大学 一种大肠杆菌与副猪嗜血杆菌穿梭载体pSHK4及制备方法与应用
US9790440B2 (en) 2011-09-23 2017-10-17 Headwaters Technology Innovation Group, Inc. Methods for increasing catalyst concentration in heavy oil and/or coal resid hydrocracker
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
CN103961695B (zh) * 2013-02-06 2016-09-07 普莱柯生物工程股份有限公司 一种预防和治疗猪呼吸道综合征的疫苗组合物及其制备方法和应用
CN103364548B (zh) * 2013-07-25 2015-03-18 江苏省农业科学院 一种副猪嗜血杆菌间接血凝检测试剂
US11414608B2 (en) 2015-09-22 2022-08-16 Hydrocarbon Technology & Innovation, Llc Upgraded ebullated bed reactor used with opportunity feedstocks
US11414607B2 (en) 2015-09-22 2022-08-16 Hydrocarbon Technology & Innovation, Llc Upgraded ebullated bed reactor with increased production rate of converted products
US11421164B2 (en) 2016-06-08 2022-08-23 Hydrocarbon Technology & Innovation, Llc Dual catalyst system for ebullated bed upgrading to produce improved quality vacuum residue product
US11118119B2 (en) 2017-03-02 2021-09-14 Hydrocarbon Technology & Innovation, Llc Upgraded ebullated bed reactor with less fouling sediment
US11732203B2 (en) 2017-03-02 2023-08-22 Hydrocarbon Technology & Innovation, Llc Ebullated bed reactor upgraded to produce sediment that causes less equipment fouling
CA3057131C (en) 2018-10-17 2024-04-23 Hydrocarbon Technology And Innovation, Llc Upgraded ebullated bed reactor with no recycle buildup of asphaltenes in vacuum bottoms

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0453024B1 (en) 1990-04-20 1995-05-31 Akzo Nobel N.V. Actinobacillus pleuropneumoniae subunit vaccine
DE69128361T3 (de) * 1990-05-29 2006-04-13 Wyeth Holdings Corp. Impfstoff gegen die pneumonie bei schweinen und verfahren zu seiner herstellung
SE466259B (sv) 1990-05-31 1992-01-20 Arne Forsgren Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
US5534256A (en) * 1992-07-02 1996-07-09 University Of Saskatchewan Haemophilus somnus outer membrane protein extract enriched with iron-regulated proteins
US5456914A (en) * 1993-01-26 1995-10-10 Board Of Regents Of The University Of Nebraska Transthoracic intrapulmonary immunization against Actinobacillus pleuropneumoniae
US5538733A (en) * 1994-07-07 1996-07-23 Willmar Poultry Company, Inc. Method of priming an immune response in a one-day old animal

Also Published As

Publication number Publication date
CA2336320A1 (en) 2000-01-13
PL345954A1 (en) 2002-01-14
US6342231B1 (en) 2002-01-29
WO2000001408A2 (en) 2000-01-13
EP1091756A2 (en) 2001-04-18
WO2000001408A3 (en) 2000-04-13
AU4730099A (en) 2000-01-24
JP2002519388A (ja) 2002-07-02
HUP0102496A3 (en) 2003-10-28
AU753763B2 (en) 2002-10-31

Similar Documents

Publication Publication Date Title
HUP0102496A2 (hu) Haemophilus parasuis vakcina és diagnosztikum
EE200300005A (et) Meetod konformse haiguse diagnoosimiseks või tuvastamiseks, selleks vajalik katsemenetlus, reaktiivikomplekt ning seade
MXPA02006145A (es) Metodo para el aislamiento de arn de especimenes de tejido incluido en parafina fijo en formalina.
WO2003071940A8 (en) Blood sampling device
HUP0203705A2 (hu) Vegyületek és eljárások Chlamydia-fertőzés kezelésére és diagnózisára
ATE205602T1 (de) Verfahren und gerät zum nachweis und zur quantifizierung von glukose in körperflüssigkeiten
WO2003077836A3 (en) Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
ATE175274T1 (de) Speicheltestverfahren und vorrichtung
EP1260178A3 (en) Technique for diagnosing attention deficit hyperactivity disorder
AU2002359620A1 (en) Consolidated body fluid testing device and method
BR9907161A (pt) Uso de um ensaio quanto à adenilato quinase em um teste in vitro, processos para determinar a suscetibilidade de uma bactéria a um reagente, para determinar a sensibilidade de uma bactéria a um antibiótico ou agente bioestático, para determinar a fase de cultivo de uma cultura bacteriana , e, kit de teste para analisar a sensibilidade de bactérias a antibióticos
PT1283907E (pt) Metodo para o diagnostico de cancros
DE60234015D1 (de) Latentes tuberkulose-diagnostisches antigen und verwendungsmethode
WO2002044739A3 (en) Method for automatically storing and reprocessing patient specimens in an automatic clinical analyzer
DE69713146T2 (de) Helicobacter pylori diagnostika
EP0902289A3 (en) Additive formulation comprising heparin-specific glucanase and use thereof
BRPI0001536A (pt) método para diagnosticar a infecção por parasitos do genero schistosoma e kit para uso no diagnóstico da infecção por schistosoma sp
WO2002103059A3 (en) Innate immunity markers for rapid diagnosis of infectious diseases
WO2003023056A3 (en) Specific markers for multiple sclerosis
BRPI0407750B8 (pt) método para detectar a presença de micoplasma em uma amostra de teste, uso de fosfato de acetila ou um seu precursor e/ou fosfato de carbamoíla ou um seu precursor, e, kit para uso na detecção de contaminação por micoplasma
WO2003068958A1 (en) Method of analyzing nucleic acid specifying gene showing change in expression dose due to schizophrenia
GB0616238D0 (en) Diagnostic Test
ATE206138T1 (de) Helicobacter pylori antigen
DE69026076D1 (de) Exkretorische/sekretorische antigene des bandwurms (cysticercus cellulosae) zur verwendung in der immundiagnostik und der impfstoffbereitung
HUP0104194A2 (hu) Módszer és készlet foszfatázcélzó toxinok kimutatására

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees